These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 22695899

  • 21. Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis.
    Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J.
    PLoS One; 2011; 6(9):e25142. PubMed ID: 21980387
    [Abstract] [Full Text] [Related]

  • 22. Homocysteine lowering interventions for preventing cardiovascular events.
    Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD006612. PubMed ID: 19821378
    [Abstract] [Full Text] [Related]

  • 23. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
    Ebbing M, Bleie Ø, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygård O.
    JAMA; 2008 Aug 20; 300(7):795-804. PubMed ID: 18714059
    [Abstract] [Full Text] [Related]

  • 24. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
    Lan X, Dang SN, Zhao YL, Yan H, Yan H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul 20; 37(7):1028-34. PubMed ID: 27453118
    [Abstract] [Full Text] [Related]

  • 25. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
    Clarke R, Armitage J.
    Semin Thromb Hemost; 2000 Jul 20; 26(3):341-8. PubMed ID: 11011852
    [Abstract] [Full Text] [Related]

  • 26. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease.
    Clarke R, Collins R.
    J Cardiovasc Risk; 1998 Aug 20; 5(4):249-55. PubMed ID: 9919473
    [No Abstract] [Full Text] [Related]

  • 27. Homocysteine lowering with folic acid and vitamin B supplements: effects on cardiovascular disease in older adults.
    Carlsson CM.
    Drugs Aging; 2006 Aug 20; 23(6):491-502. PubMed ID: 16872232
    [Abstract] [Full Text] [Related]

  • 28. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals.
    Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R, B-Vitamin Treatment Trialists' Collaboration.
    Arch Intern Med; 2010 Oct 11; 170(18):1622-31. PubMed ID: 20937919
    [Abstract] [Full Text] [Related]

  • 29. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R, Grimley Evans J.
    Cochrane Database Syst Rev; 2008 Oct 08; (4):CD004514. PubMed ID: 18843658
    [Abstract] [Full Text] [Related]

  • 30. The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials.
    Liu Y, Tian T, Zhang H, Gao L, Zhou X.
    Atherosclerosis; 2014 Jul 08; 235(1):31-5. PubMed ID: 24814647
    [Abstract] [Full Text] [Related]

  • 31. Dietary interventions for adults with chronic kidney disease.
    Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GF.
    Cochrane Database Syst Rev; 2017 Apr 23; 4(4):CD011998. PubMed ID: 28434208
    [Abstract] [Full Text] [Related]

  • 32. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M, Grimley EJ, Areosa SA.
    Cochrane Database Syst Rev; 2003 Apr 23; (4):CD004514. PubMed ID: 14584018
    [Abstract] [Full Text] [Related]

  • 33. Antioxidants for chronic kidney disease.
    Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008176. PubMed ID: 23076940
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials.
    Yang HT, Lee M, Hong KS, Ovbiagele B, Saver JL.
    Eur J Intern Med; 2012 Dec 17; 23(8):745-54. PubMed ID: 22884409
    [Abstract] [Full Text] [Related]

  • 35. Homocysteine and renal disease.
    van Guldener C, Robinson K.
    Semin Thromb Hemost; 2000 Dec 17; 26(3):313-24. PubMed ID: 11011849
    [Abstract] [Full Text] [Related]

  • 36. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.
    Bazzano LA, Reynolds K, Holder KN, He J.
    JAMA; 2006 Dec 13; 296(22):2720-6. PubMed ID: 17164458
    [Abstract] [Full Text] [Related]

  • 37. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
    Hooper L, Al-Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, Ajabnoor SM, O'Brien AT, Winstanley LE, Donaldson DH, Song F, Deane KH.
    Cochrane Database Syst Rev; 2018 Nov 29; 11(11):CD011094. PubMed ID: 30488422
    [Abstract] [Full Text] [Related]

  • 38. Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
    Schmucker C, Eisele-Metzger A, Meerpohl JJ, Lehane C, Kuellenberg de Gaudry D, Lohner S, Schwingshackl L.
    Cochrane Database Syst Rev; 2022 Feb 24; 2(2):CD013556. PubMed ID: 35199850
    [Abstract] [Full Text] [Related]

  • 39. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
    Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M, DACH-LIGA Homocystein e.V.
    Clin Chem Lab Med; 2003 Nov 24; 41(11):1392-403. PubMed ID: 14656016
    [Abstract] [Full Text] [Related]

  • 40. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
    Booth GL, Wang EE.
    CMAJ; 2000 Jul 11; 163(1):21-9. PubMed ID: 10920726
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.